Page 4 - Berndr Seizinger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Berndr seizinger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Berndr Seizinger Today - Breaking & Trending Today

Aptose Biosciences Inc. (NASDAQ:APTO) Sees Significant Decline in Short Interest

Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the recipient of a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 29,200 shares, a drop of 22.8% from the August 31st total of 37,800 shares. Based on an average daily trading volume, of […] ....

Piper Sandler , Berndr Seizinger , Aptose Biosciences , Aptose Biosciences Company Profile , Securities Exchange Commission , Aptose Biosciences Inc , Renaissance Technologies , Cantor Fitzgerald , Millennium Management , Royal Bank , Cetera Advisors , Sequoia Financial Advisors , Callan Capital , Get Free Report , Director Bernd , Exchange Commission , Financial Advisors , Biosciences Inc , Aptose Biosciences Daily , Nasdaq Apto ,

Insider Buying: Aprea Therapeutics, Inc. (NASDAQ:APRE) Director Purchases $14,766.84 in Stock

Aprea Therapeutics, Inc. (NASDAQ:APRE – Get Rating) Director Bernd R. Seizinger acquired 4,068 shares of the business’s stock in a transaction on Tuesday, June 6th. The stock was purchased at an average cost of $3.63 per share, with a total value of $14,766.84. Following the acquisition, the director now directly owns 20,296 shares of the […] ....

Berndr Seizinger , Millennium Management , Securities Exchange Commission , Aprea Therapeutics Inc , Maxim Group , Sio Capital Management , Capital Management , Aprea Therapeutics , Get Rating , Director Bernd , Exchange Commission , Jane Street Group , Aprea Therapeutics Daily ,

Aprea Therapeutics, Inc. (NASDAQ:APRE) Director Bernd R. Seizinger Buys 4,068 Shares

Aprea Therapeutics, Inc. (NASDAQ:APRE – Get Rating) Director Bernd R. Seizinger acquired 4,068 shares of Aprea Therapeutics stock in a transaction dated Tuesday, June 6th. The shares were bought at an average cost of $3.63 per share, with a total value of $14,766.84. Following the completion of the purchase, the director now owns 20,296 shares […] ....

Berndr Seizinger , Millennium Management , Aprea Therapeutics Inc , Sio Capital Management , Capital Management , Maxim Group , Aprea Therapeutics , Get Rating , Director Bernd , Jane Street Group , Aprea Therapeutics Daily , Nasdaq Apre , Insider Trading , Nsider Trades ,

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

/PRNewswire/ Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced the voting results from its Annual General Meeting (AGM) of Shareholders. ....

Berndr Seizinger , Wayne Pisano , Jonathan Rigby , Deborahm Brown , Jon Patton , Matthewc Coffey , Jamest Parsons , Angela Holtham , Timothy Mccarthy , Company Contact , Oncolytics Biotech Inc , Oncolytics Biotech , Annual General Meeting , Annual Meeting , Oncolytics Biotech Inc ,

Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 9, 2023 - Form 6-K

NOTICE OF ANNUAL GENERAL MEETING

OF SHAREHOLDERS TO BE HELD ON MAY 9, 2023

- AND -

MANAGEMENT INFORMATION CIRCULAR

. | April 6, 2023 ....

United States , United Kingdom , New York , New Jersey , Princeton University , University Of Dayton , Leonard Kruimer , Matt Coffey , Bristol Myers Squibb , Thomasc Heineman , Jonathan Rigby , Allison Hagerman , Deborah Brown , Michael Bennett , Wayne Pisano , Deborahm Brown , Jamest Parsons , Aptose Biosciences , James Parsons , Matthewc Coffey , Bernd Seizinger , Revolo Biotherapeutics , Sanofi Pasteur , Angela Holtham , Berndr Seizinger , Management Of The Corporation ,